s6y
Company name or ticker
Search
Telix Pharmaceuticals Ltd
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Filed
Tuesday, July 21, 2026
Period
Jun 30, 2026
Accession number
0001628280-26-048922
Documents
6-K
6-K
EX-99.1
EX-99.1
On sec.gov
Filing index
All files
Complete submission text
SGML header